FACTOR VII DEFICIENCY
Clinical trials for FACTOR VII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new FACTOR VII DEFICIENCY trials appear
Sign up with your email to follow new studies for FACTOR VII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThis study tests an experimental injection called SR604 in 76 adults with hemophilia A, B, or congenital factor VII deficiency. The goal is to see if it is safe and can reduce bleeding episodes. Participants will receive either a single dose or multiple doses, and researchers wil…
Matched conditions: FACTOR VII DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hemophilia drug enters human safety trials
Disease control Recruiting nowThis early-stage study tests a new drug called SR604 in healthy people and those with hemophilia A, B, or factor VII deficiency. The main goal is to check safety and how the drug moves through the body. About 31 participants will receive single or multiple doses to find the right…
Matched conditions: FACTOR VII DEFICIENCY
Phase: PHASE1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC